Responses
Immune cell therapies and immune cell engineering
Original research
Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells
Compose a Response to This Article
Other responses
No responses have been published for this article.